Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Chris Lindsay, a BHF CRE funded DPhil student jointly supervised by Angela Russell and Rebecca Sitsapesan, has been awarded the poster prize at the British Pharmacological Society meeting in Edinburgh - Pharmacology Futures. The conference focused on exploring the technologies that will drive drug development over the next 10 to 15 years, with speakers sharing their visions of the future. Chris presented his work on using electrophysiology to elucidate the mechanism of statin side effects, towards the development of next generation HMG-CoA inhibitors.

Similar stories

New molecule found to suppress bacterial antibiotic resistance evolution

Researchers in the Lanyon-Hogg group in the Department of Pharmacology, in collaboration with the Ineos Oxford Institute for antimicrobial research (IOI), have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics. The findings have been published in the journal Chemical Science.